Skip to Content
Merck
  • High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

Chemistry & biology (2011-08-02)
Chandrasekhar V Miduturu, Xianming Deng, Nicholas Kwiatkowski, Wannian Yang, Laurent Brault, Panagis Filippakopoulos, Eunah Chung, Qingkai Yang, Juerg Schwaller, Stefan Knapp, Randall W King, Jiing-Dwan Lee, Sanna Herrgard, Patrick Zarrinkar, Nathanael S Gray
ABSTRACT

Selective protein kinase inhibitors have only been developed against a small number of kinase targets. Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compounds for established as well as unexplored kinase targets. We screened a library of 118 compounds constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases. A distinct kinase selectivity profile was observed for each scaffold. Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases. In addition, we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation. This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
XMD8-87, ≥98% (HPLC)